Rakesh Bamzai is President of India, Emerging Asia & Access Markets; Commercial Expansion & Biosimilars –Emerging Markets at Mylan Pharmaceuticals Private Limited, a Viatris Company. Based in Bangalore, Rakesh has close to three decades of experience in the Indian and global biopharmaceutical industry.
In his current role, Rakesh is responsible for leading Commercial Operations for Viatris’ branded, branded generics, generics, biosimilars, antiretroviral (ARV) and active pharmaceutical ingredient (API) businesses in India and Emerging Markets. During his tenure with Mylan, Rakesh has championed various initiatives to transform Mylan’s businesses across the highly dynamic countries within the region. He has been instrumental in establishing a robust commercial and distribution platform and forged strategic partnerships with the aim of enhancing access and affordability in line with the company’s vision. Further, he has led multiple integration efforts to consolidate and streamline businesses within Mylan’s India and Emerging Markets region.
Rakesh also has developed an expertise in the global biopharmaceutical business throughout his career and has a track record of scaling up businesses from scratch. With a keen eye for leveraging valuable therapies and portfolios that fulfill unmet needs, he has led marketing efforts that have influenced development pipelines created successful pillar brands across therapies in various international markets.
Rakesh studied Chemical Technology at the University Department of Chemical Technology, now known as the Institute of Chemical Technology at the University of Mumbai, where he was named a ‘Distinguished Alumni’ by the Vice Chancellor of the university.